These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24722948)

  • 21. Hordenine protects against hyperglycemia-associated renal complications in streptozotocin-induced diabetic mice.
    Su S; Cao M; Wu G; Long Z; Cheng X; Fan J; Xu Z; Su H; Hao Y; Li G; Peng J; Li S; Wang X
    Biomed Pharmacother; 2018 Aug; 104():315-324. PubMed ID: 29775900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperglycemia-induced Renal P2X7 Receptor Activation Enhances Diabetes-related Injury.
    Menzies RI; Booth JWR; Mullins JJ; Bailey MA; Tam FWK; Norman JT; Unwin RJ
    EBioMedicine; 2017 May; 19():73-83. PubMed ID: 28434946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of sulfonylureas, alpha-endosulfine counterparts, on glomerulosclerosis in type 1 and type 2 models of diabetes.
    Biederman JI; Vera E; Rankhaniya R; Hassett C; Giannico G; Yee J; Cortes P
    Kidney Int; 2005 Feb; 67(2):554-65. PubMed ID: 15673303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppressors of cytokine signaling abrogate diabetic nephropathy.
    Ortiz-Muñoz G; Lopez-Parra V; Lopez-Franco O; Fernandez-Vizarra P; Mallavia B; Flores C; Sanz A; Blanco J; Mezzano S; Ortiz A; Egido J; Gomez-Guerrero C
    J Am Soc Nephrol; 2010 May; 21(5):763-72. PubMed ID: 20185635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB
    González-Mariscal I; Carmona-Hidalgo B; Winkler M; Unciti-Broceta JD; Escamilla A; Gómez-Cañas M; Fernández-Ruiz J; Fiebich BL; Romero-Zerbo SY; Bermúdez-Silva FJ; Collado JA; Muñoz E
    Pharmacol Res; 2021 Jul; 169():105492. PubMed ID: 34019978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-27a Induces Mesangial Cell Injury by Targeting of PPARγ, and its In Vivo Knockdown Prevents Progression of Diabetic Nephropathy.
    Wu L; Wang Q; Guo F; Ma X; Ji H; Liu F; Zhao Y; Qin G
    Sci Rep; 2016 May; 6():26072. PubMed ID: 27184517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy.
    Jourdan T; Park JK; Varga ZV; Pálóczi J; Coffey NJ; Rosenberg AZ; Godlewski G; Cinar R; Mackie K; Pacher P; Kunos G
    Diabetes Obes Metab; 2018 Mar; 20(3):698-708. PubMed ID: 29106063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy.
    Hinden L; Udi S; Drori A; Gammal A; Nemirovski A; Hadar R; Baraghithy S; Permyakova A; Geron M; Cohen M; Tsytkin-Kirschenzweig S; Riahi Y; Leibowitz G; Nahmias Y; Priel A; Tam J
    J Am Soc Nephrol; 2018 Feb; 29(2):434-448. PubMed ID: 29030466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential.
    Chen HY; Huang XR; Wang W; Li JH; Heuchel RL; Chung AC; Lan HY
    Diabetes; 2011 Feb; 60(2):590-601. PubMed ID: 20980457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trans-resveratrol mitigates type 1 diabetes-induced oxidative DNA damage and accumulation of advanced glycation end products in glomeruli and tubules of rat kidneys.
    Al-Hussaini H; Kilarkaje N
    Toxicol Appl Pharmacol; 2018 Jan; 339():97-109. PubMed ID: 29229234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of calcineurin/NFAT pathway plays an essential role in renoprotective effect of tropisetron in early stage of diabetic nephropathy.
    Barzegar-Fallah A; Alimoradi H; Razmi A; Dehpour AR; Asgari M; Shafiei M
    Eur J Pharmacol; 2015 Nov; 767():152-9. PubMed ID: 26481166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hedgehog Interacting Protein Promotes Fibrosis and Apoptosis in Glomerular Endothelial Cells in Murine Diabetes.
    Zhao XP; Chang SY; Liao MC; Lo CS; Chenier I; Luo H; Chiasson JL; Ingelfinger JR; Chan JSD; Zhang SL
    Sci Rep; 2018 Apr; 8(1):5958. PubMed ID: 29654303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of growth-related protooncogenes during diabetic renal hypertrophy.
    Shankland SJ; Scholey JW
    Kidney Int; 1995 Mar; 47(3):782-8. PubMed ID: 7752577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proximal Tubular Cannabinoid-1 Receptor Regulates Obesity-Induced CKD.
    Udi S; Hinden L; Earley B; Drori A; Reuveni N; Hadar R; Cinar R; Nemirovski A; Tam J
    J Am Soc Nephrol; 2017 Dec; 28(12):3518-3532. PubMed ID: 28860163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of EphA1-Epha receptor axis attenuates diabetic nephropathy in mice.
    Li Y; Yan H; Wang F; Huang S; Zhang Y; Wang Z; Zhong M; Zhang W
    Biochem Biophys Res Commun; 2017 May; 486(3):693-699. PubMed ID: 28341121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli.
    Xu ZG; Miao LN; Cui YC; Jia Y; Yuan H; Wu M
    Nephrol Dial Transplant; 2009 Jun; 24(6):1744-52. PubMed ID: 19103735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of upstream stimulatory factor 2 accelerates diabetic kidney injury.
    Liu S; Shi L; Wang S
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1727-35. PubMed ID: 17881461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lovastatin inhibits transforming growth factor-beta1 expression in diabetic rat glomeruli and cultured rat mesangial cells.
    Kim SI; Han DC; Lee HB
    J Am Soc Nephrol; 2000 Jan; 11(1):80-87. PubMed ID: 10616843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient gain of function of cannabinoid CB
    Pedro JR; Moura LIF; Valério-Fernandes Â; Baptista FI; Gaspar JM; Pinheiro BS; Lemos C; Kaufmann FN; Morgado C; Silva-Santos CSD; Tavares I; Ferreira SG; Carvalho E; Ambrósio AF; Cunha RA; Duarte JMN; Köfalvi A
    Brain Res Bull; 2020 Aug; 161():106-115. PubMed ID: 32428627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CB1 cannabinoid receptor antagonist attenuates left ventricular hypertrophy and Akt-mediated cardiac fibrosis in experimental uremia.
    Lin CY; Hsu YJ; Hsu SC; Chen Y; Lee HS; Lin SH; Huang SM; Tsai CS; Shih CC
    J Mol Cell Cardiol; 2015 Aug; 85():249-61. PubMed ID: 26093151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.